NFE2L3 and colorectal cancer: Moreover, studies have shown that the overexpression of CDK1 in colorectal cancer [15, 16], and the authors found that the decreased proliferation of colorectal cancer cells after NFE2L3 knockout may be due to the decreased CDK1 activity [15].